Valtya 1/35 Kit
Product Images NDC 70700-304

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Valtya 1/35 (NDC 70700-304). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (E76714c0 97e3 4030 Baba 0b4caf86ac34 01)

FDA Label Image

Graph (E76714c0 97e3 4030 Baba 0b4caf86ac34 02)

Graph (E76714c0 97e3 4030 Baba 0b4caf86ac34 02)
This text appears to be presenting mortality rates with a comparison between different groups based on age and smoking status. The data includes information on the number of deaths per 100,000 woman-years and seems to depict a comparison between ever-users who are non-smokers versus smokers, as well as controls who are non-smokers versus smokers in different age groups. The mortality rates are shown graphically with a percentage scale indicating different age ranges.*
FDA Label Image

Blister (E76714c0 97e3 4030 Baba 0b4caf86ac34 03)

Blister (E76714c0 97e3 4030 Baba 0b4caf86ac34 03)
This text provides details about a medication named Valtya 1/35, which contains Ethynodiol Diacetate and Ethinyl Estradiol in tablet form. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F). The product contains 28 tablets and includes a set of reminder pills in light orange and green colors.*
FDA Label Image

3s Carton (Image 01)

3s Carton (Image 01)
This text contains information about Valtya™ 1/35, which is a contraceptive tablet containing Ethynodiol Diacetate and Ethinyl Estradiol. This medication comes in a pack of 28 tablets and is used for birth control purposes.*
FDA Label Image

Figure 2. Risk Of Breast Cancer With Combined Oral Contraceptive Use (Image 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.